Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of SGR-1505 in Mature B-Cell Neoplasms
Sponsor: Schrödinger, Inc.
Summary
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.
Official title: A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
98
Start Date
2023-04-10
Completion Date
2027-11
Last Updated
2026-02-13
Healthy Volunteers
No
Conditions
Interventions
SGR-1505
SGR-1505 will be administered orally.
Locations (36)
Banner Health - MD Anderson Cancer Center
Gilbert, Arizona, United States
Christiana Care Hospital - Helen F Graham Cancer Center
Newark, Delaware, United States
Napa Research
Pompano Beach, Florida, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Regional Cancer Care Associates
Hackensack, New Jersey, United States
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Weill Cornell
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Duke University
Durham, North Carolina, United States
Gabrail Cancer & Research Center
Canton, Ohio, United States
The Ohio State University - The James Cancer Hospital
Columbus, Ohio, United States
Oregon Health and Science University - Knight Cancer Institute
Portland, Oregon, United States
Rhode Island Hospital
Providence, Rhode Island, United States
University of Texas Southwestern
Dallas, Texas, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
AP-HP Hôpital Henri-Mondor
Créteil, France
Institut Gustave Roussy
Villejuif, France
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo - Presidio Ospedaliero SS Antonio e Biagio e Cesare Arrigo, Ospedale Civile
Alessandria, Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
IRCCS Ospedale San Raffaele
Milan, Italy
AOU Citta della Salute e della Scienza di Torino - Ospedale le Molinette
Torino, Italy
Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma
Verona, Italy
Institute of Oncology, ARENSIA Exploratory Medicine
Chisinau, Moldova
Uniwersyteckie Centrum Kliniczne, Osrodek Badan Klinicznych Wczesnych Faz
Gdansk, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
Lodz, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie
Warsaw, Poland
ARENSIA Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti
Bucharest, Romania
ARENSIA Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca
Cluj-Napoca, Romania
Institut Catala d'Oncologia - L'Hospitalet
Barcelona, Spain
Hospital Universitario Quironsalud Madrid
Madrid, Spain
START Madrid - CIOCC
Madrid, Spain
START Madrid - Hospital Fundacion Jimenez Diaz
Madrid, Spain
Clinica Universidad de Navarra - Pamplona
Pamplona, Spain
Hospital Clinico Universitario de Salamanca
Salamanca, Spain
ARENSIA Research Clinic at Harmony Health Clinic
Kyiv, Ukraine